Abstract:Objective In association with innate and adaptive immunity, the microbiota controls the colonisation resistance against intestinal pathogens. Caspase recruitment domain 9 ( CARD9 ), a key innate immunity gene, is required to shape a normal gut microbiota. Card9 –/– mice are more susceptible to the enteric mouse pathogen Citrobacter rodentium that mimics human infections with enteropathogenic and enterohaemorrhagic Escherichia coli . Here, we examined how CARD9 controls C. rodentium infection susceptibility through microbiota-dependent and microbiota-independent mechanisms. Design C. rodentium infection was assessed in conventional and germ-free (GF) wild-type (WT) and Card9 –/– mice. To explore the impact of Card9 –/– microbiota in infection susceptibility, GF WT mice were colonised with WT (WT→GF) or Card9 –/– ( Card9 –/– →GF) microbiota before C. rodentium infection. Microbiota composition was determined by 16S rDNA gene sequencing. Inflammation severity was determined by histology score and lipocalin level. Microbiota–host immune system interactions were assessed by quantitative PCR analysis. Results CARD9 controls pathogen virulence in a microbiota-independent manner by supporting a specific humoral response. Higher susceptibility to C. rodentium -induced colitis was observed in Card9 –/– →GF mice. The microbiota of Card9 –/– mice failed to outcompete the monosaccharide-consuming C. rodentium , worsening the infection severity. A polysaccharide-enriched diet counteracted the ecological advantage of C. rodentium and the defective pathogen-specific antibody response in Card9 –/– mice. Conclusions CARD9 modulates the susceptibility to intestinal infection by controlling the pathogen virulence in a microbiota-dependent and microbiota-independent manner. Genetic susceptibility to intestinal pathogens can be overridden by diet intervention that restores humoural immunity and a competing microbiota.

The adaptor molecule CARD9 is essential for tuberculosis control

The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens

The roles of CARD9 in immune responses against intracellular bacterial infection

The adaptor protein CARD9, from fungal immunity to tumorigenesis

Lack of Myd88 Protects the Immunodeficient Host Against Fatal Lung Inflammation Triggered by the Opportunistic Bacteria Burkholderia Cenocepacia

Card9 Broadly Regulates Host Immunity against Experimental Pulmonary Cryptococcus neoformans 52D Infection

Deletion of Card9 eliminates the detrimental facets of mycobacterial adjuvants

Chronic pneumonia despite adaptive immune response to Mycobacterium bovis BCG in MyD88-deficient mice

The Roles of CARD9 in Immune Responses Against Intracellular Bacterial Infection (B170)

Partial Redundancy of the Pattern Recognition Receptors, Scavenger Receptors, and C-Type Lectins for the Long-Term Control of Mycobacterium Tuberculosis Infection

Prominent Role for T Cell-Derived Tumour Necrosis Factor for Sustained Control of Mycobacterium Tuberculosis Infection

Fatal Mycobacterium Tuberculosis Infection Despite Adaptive Immune Response in the Absence of MyD88

Partial Redundancy of the Pattern Recognition Receptors, Scavenger Receptors, and C-Type Lectins for the Long-Term Control of<i>Mycobacterium</i><i>tuberculosis</i>Infection

DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infection

Role of CARD9 in Cell- and Organ-Specific Immune Responses in Various Infections

CpsA mediates infection of recruited lung myeloid cells by Mycobacterium tuberculosis

IL-1 Receptor-Mediated Signal is an Essential Component of MyD88-dependent Innate Response to Mycobacterium Tuberculosis Infection.

Innate Immunity to Mycobacterial Infection in Mice: Critical Role for Toll-Like Receptors

The Adaptor Protein CARD9 Protects Against Colon Cancer by Restricting Mycobiota-Mediated Expansion of Myeloid-Derived Suppressor Cells.

Innate Myeloid Cell Tnfr1 Mediates First Line Defence Against Primary Mycobacterium Tuberculosis Infection

Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence